Stay updated on Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page
- Check7 days agoChange DetectedThe page shows an updated revision label: Revision: v3.4.1 replacing Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded UI options to Show glossary and Hide glossary, and updated non-substantive text labels including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new revision indicator (Revision: v3.4.0). Removed older labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.1%

- Check28 days agoChange DetectedThe update is limited to revision metadata, changing from v3.3.3 to v3.3.4; there are no changes to core study content or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedDifference2%

- Check79 days agoChange DetectedPublications section updated to clarify PubMed-based data population and to note Revision: v3.3.2, replacing the prior v3.2.0 wording. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check86 days agoChange DetectedThe general government funding/operating status notice was removed from the page.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Cisplatin-Ineligible UC Clinical Trial page.